세계의 의료용 AI 시장 2019-2027 : 제공방식별 (하드웨어, 소프트웨어, 서비스), 알고리즘별, 용도별, 최종 사용자별

■ 영문 제목 : AI in Healthcare Market by Offering (Hardware, Software, and Services), Algorithm (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing) Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End user (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Patients, and Payer): Global Opportunity Analysis and Industry Forecast, 2019-2027

Allied Market Research가 발행한 조사보고서이며, 코드는 AMR20PL047 입니다.■ 상품코드 : AMR20PL047
■ 조사/발행회사 : Allied Market Research
■ 발행일 : 2020년 6월
■ 페이지수 : 301
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 건강 관리
■ 판매가격 / 옵션 (부가세별도)
Single UserUSD5,769 ⇒환산₩6,345,900견적의뢰/주문/질문
5 UserUSD6,450 ⇒환산₩7,095,000견적의뢰/주문/질문
Enterprise UserUSD8,995 ⇒환산₩9,894,500견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사 리포트는 세계의 의료용 AI 시장을 조사/분석하여, 소개, 개요, 시장 동향, 제공방식별 (하드웨어, 소프트웨어, 서비스) 분석, 알고리즘별 (딥러닝, 질의 방법, 자연어 처리, 상황 인식 처리) 분석, 용도별 (로봇 지원 수술, 가상 간호 보조, 관리 워크 플로우 지원, 가품 감지, 용량 오류 감소) 분석, 최종 사용자별 (의료 서비스 제공자, 제약/생명 공학 회사, 환자, 지불자) 분석, 지역별 분석, 기업 정보 등의 항목을 게재하고 있습니다.

・ 소개
・ 개요
・ 시장 동향
・ 세계의 의료용 AI 시장규모 : 제공방식별 (하드웨어, 소프트웨어, 서비스)
・ 세계의 의료용 AI 시장규모 : 알고리즘별 (딥러닝, 질의 방법, 자연어 처리, 상황 인식 처리)
・ 세계의 의료용 AI 시장규모 : 용도별 (로봇 지원 수술, 가상 간호 보조, 관리 워크 플로우 지원, 가품 감지, 용량 오류 감소)
・ 세계의 의료용 AI 시장규모 : 최종 사용자별 (의료 서비스 제공자, 제약/생명 공학 회사, 환자, 지불자)
・ 세계의 의료용 AI 시장규모 : 지역별
・ 기업 정보
■ 보고서 개요

The AI in healthcare market was valued at $4,836.87million in 2019 and is projected to reach $99,491.58 million by 2027, registering a CAGR of 42.8% from 2020 to 2027.Artificial intelligence (AI) can be defined as the science and engineering adopted to design intelligent machines, especially intelligent computer programs. AI is an intelligent system that applies various human intelligence based functions such as reasoning, learning, and problem-solving skills on different disciplines such as biology, computer science, mathematics, linguistics, psychology, and engineering. AI is widely applicable in medication management, treatment plans, and drug discovery.
The growth of the AI in healthcare market is driven by the ability of AI to improve patient outcomes, need to increase coordination between healthcare workforce & patients, increase in adoption of precision medicine, and a notable rise in venture capital investments. In addition, rise in importance of big data in healthcare is expected to fuel the market growth.

The market is expected to witness a moderate growth during the forecast period, owing to rise in adoption of AI systems. Furthermore, technological advancements in AI systems are anticipated to augment the market growth. Prospective of AI-based tools for elderly care and the untapped potential of emerging markets, such as China and India, are expected to present various opportunities for market expansion. However, an imprecise regulatory scenario and reluctance among healthcare professionals to adopt AI-based technologies are expected to hamper the market growth.

The AI in healthcare market is segmented based on offering, algorithm, application, end user, and region. On the basis of offering, the market is divided into hardware, software, and services. By algorithm, it is classified into deep learning, querying method, natural language processing, and context aware processing. The application segment includes robot-assisted surgery, virtual nursing assistant, administrative workflow assistance, fraud detection, dosage error reduction, clinical trial participant identifier, preliminary diagnosis, and others. Depending on end user, the market is fragmented into healthcare providers, pharmaceutical & Biotechnology Companies, patients, and payer. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
ü This report entails a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027 to identify the prevailing opportunities.
ü Market estimations are based on comprehensive analysis of the key developments in the industry.
ü The global market is comprehensively analyzed with respect to offering, algorithm, application, end user, and region.
ü In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
ü The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS
• By Offering
o Hardware
o Software
o Services

• By Algorithm
o Deep Learning
o Querying Method
o Natural Language Processing
o Context Aware Processing

• By Application
o Robot-assisted Surgery
o Virtual Nursing Assistant
o Administrative Workflow Assistance
o Fraud Detection
o Dosage Error Reduction
o Clinical Trial Participant Identifier
o Preliminary Diagnosis
o Others

• By End User
o Healthcare Providers
o Pharmaceutical & Biotechnology Company
o Patients
o Payers

• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
o Asia-Pacific
• Australia
• Japan
• India
• China
• South Korea
• Rest of Asia-Pacific
o LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• Rest of LAMEA

KEY MARKET PLAYERS
• Alphabet Inc. (Google Inc.)
• Enlitic Inc
• General Vision
• iCarbonX
• Intel Corporation
• IBM Corporation
• Microsoft Corporation
• Nvidia Corporation
• Next IT Corp
• Welltok Inc.

■ 보고서 목차

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Subsidy programs and funding
3.4.Porter’s five forces analysis
3.5.Regulations and reimbursement scenario
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Increase in processing power of AI systems leading to enhanced AI capabilities
3.6.1.2.Dearth of skilled healthcare professionals
3.6.1.3.Application of AI for novel surgeries and screening

3.6.2.Restraints

3.6.2.1.Limitations of AI decision-making
3.6.2.2.Limited acceptance from healthcare professionals owing to risk of injury and misinterpretation

3.6.3.Opportunities

3.6.3.1.Untapped market in developing regions

3.7.Impact of Covid-19 on the market

CHAPTER 4:ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING

4.1.Overview

4.1.1.Market size and forecast

4.2.Hardware

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Software

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Services

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHM

5.1.Overview

5.1.1.Market size and forecast

5.2.Deep learning

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Querying method

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Natural language processing

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Context aware processing

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Robot-assisted surgery

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Virtual nursing assistant

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Administrative workflow assistance

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Fraud detection

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

6.6.Dosage error reduction

6.6.1.Market size and forecast
6.6.2.Market analysis, by country

6.7.Clinical trial participant identifier

6.7.1.Market size and forecast
6.7.2.Market analysis, by country

6.8.Preliminary diagnosis

6.8.1.Market size and forecast
6.8.2.Market analysis, by country

6.9.Others

6.9.1.Market size and forecast
6.9.2.Market analysis, by country

CHAPTER 7:ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Healthcare providers

7.2.1.Market size and forecast
7.2.2.Market analysis, by country

7.3.Pharmaceuticals & biotechnology companies

7.3.1.Market size and forecast
7.3.2.Market analysis, by country

7.4.Patients

7.4.1.Market size and forecast
7.4.2.Market analysis, by country

7.5.Payer

7.5.1.Market size and forecast
7.5.2.Market analysis, by country

CHAPTER 8:ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.Market size and forecast, by offering
8.2.3.Market size and forecast, by algorithms
8.2.4.Market size and forecast, by application
8.2.5.Market size and forecast, by end user
8.2.6.Market size and forecast, by country

8.2.6.1.U.S. Market size and forecast, by offering
8.2.6.2.U.S. Market size and forecast, by algorithms
8.2.6.3.U.S. Market size and forecast, by application
8.2.6.4.U.S. Market size and forecast, by end user
8.2.6.5.Canada Market size and forecast, by offering
8.2.6.6.Canada Market size and forecast, by algorithms
8.2.6.7.Canada Market size and forecast, by application
8.2.6.8.Canada Market size and forecast, by end user
8.2.6.9.Mexico Market size and forecast, by offering
8.2.6.10.Mexico Market size and forecast, by algorithms
8.2.6.11.Mexico Market size and forecast, by application
8.2.6.12.Mexico Market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Market size and forecast, by offering
8.3.3.Market size and forecast, by algorithms
8.3.4.Market size and forecast, by application
8.3.5.Market size and forecast, by end user
8.3.6.Market size and forecast, by country

8.3.6.1.Germany Market size and forecast, by offering
8.3.6.2.Germany Market size and forecast, by algorithms
8.3.6.3.Germany Market size and forecast, by application
8.3.6.4.Germany Market size and forecast, by end user
8.3.6.5.France Market size and forecast, by offering
8.3.6.6.France Market size and forecast, by algorithms
8.3.6.7.France Market size and forecast, by application
8.3.6.8.France Market size and forecast, by end user
8.3.6.9.UK Market size and forecast, by offering
8.3.6.10.UK Market size and forecast, by algorithms
8.3.6.11.UK Market size and forecast, by application
8.3.6.12.UK Market size and forecast, by end user
8.3.6.13.Italy Market size and forecast, by offering
8.3.6.14.Italy Market size and forecast, by algorithms
8.3.6.15.Italy Market size and forecast, by application
8.3.6.16.Italy Market size and forecast, by end user
8.3.6.17.Spain Market size and forecast, by offering
8.3.6.18.Spain Market size and forecast, by algorithms
8.3.6.19.Spain Market size and forecast, by application
8.3.6.20.Spain Market size and forecast, by end user
8.3.6.21.Rest of Europe Market size and forecast, by offering
8.3.6.22.Rest of Europe Market size and forecast, by algorithms
8.3.6.23.Rest of Europe Market size and forecast, by application
8.3.6.24.Rest of Europe Market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Market size and forecast, by offering
8.4.3.Market size and forecast, by algorithms
8.4.4.Market size and forecast, by application
8.4.5.Market size and forecast, by end user
8.4.6.Market size and forecast, by country

8.4.6.1.Japan Market size and forecast, by offering
8.4.6.2.Japan Market size and forecast, by algorithms
8.4.6.3.Japan Market size and forecast, by application
8.4.6.4.Japan Market size and forecast, by end user
8.4.6.5.China Market size and forecast, by offering
8.4.6.6.China Market size and forecast, by algorithms
8.4.6.7.China Market size and forecast, by application
8.4.6.8.China Market size and forecast, by end user
8.4.6.9.Australia Market size and forecast, by offering
8.4.6.10.Australia Market size and forecast, by algorithms
8.4.6.11.Australia Market size and forecast, by application
8.4.6.12.Australia Market size and forecast, by end user
8.4.6.13.India Market size and forecast, by offering
8.4.6.14.India Market size and forecast, by algorithms
8.4.6.15.India Market size and forecast, by application
8.4.6.16.India Market size and forecast, by end user
8.4.6.17.South Korea Market size and forecast, by offering
8.4.6.18.South Korea Market size and forecast, by algorithms
8.4.6.19.South Korea Market size and forecast, by application
8.4.6.20.South Korea Market size and forecast, by end user
8.4.6.21.Taiwan Market size and forecast, by offering
8.4.6.22.Taiwan Market size and forecast, by algorithms
8.4.6.23.Taiwan Market size and forecast, by application
8.4.6.24.Taiwan Market size and forecast, by end user
8.4.6.25.Rest of Asia-Pacific Market size and forecast, by offering
8.4.6.26.Rest of Asia-Pacific Market size and forecast, by algorithms
8.4.6.27.Rest of Asia-Pacific Market size and forecast, by application
8.4.6.28.Rest of Asia-Pacific Market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.Market size and forecast, by offering
8.5.3.Market size and forecast, by algorithms
8.5.4.Market size and forecast, by application
8.5.5.Market size and forecast, by end user
8.5.6.Market size and forecast, by country

8.5.6.1.Brazil Market size and forecast, by offering
8.5.6.2.Brazil Market size and forecast, by algorithms
8.5.6.3.Brazil Market size and forecast, by application
8.5.6.4.Brazil Market size and forecast, by end user
8.5.6.5.Saudi Arabia Market size and forecast, by offering
8.5.6.6.Saudi Arabia Market size and forecast, by algorithms
8.5.6.7.Saudi Arabia Market size and forecast, by application
8.5.6.8.Saudi Arabia Market size and forecast, by end user
8.5.6.9.South Africa Market size and forecast, by offering
8.5.6.10.South Africa Market size and forecast, by algorithms
8.5.6.11.South Africa Market size and forecast, by application
8.5.6.12.South Africa Market size and forecast, by end user
8.5.6.13.Rest of LAMEA Market size and forecast, by offering
8.5.6.14.Rest of LAMEA Market size and forecast, by algorithms
8.5.6.15.Rest of LAMEA Market size and forecast, by application
8.5.6.16.Rest of LAMEA Market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.Alphabet Inc. (Google Inc.)

9.1.1.Company overview
9.1.1.Company snapshot
9.1.2.Operating business segments
9.1.3.Product portfolio
9.1.4.Business performance

9.2.Enlitic Inc.

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Product portfolio
9.2.4.Key strategic moves and developments

9.3.General Vision

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments

9.4.iCarbonX

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Product portfolio
9.4.4.Key strategic moves and developments

9.5.Intel Corporation

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments

9.6.IBM Corporation

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.Microsoft Corporation

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.Nvidia Corporation

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.Next IT Corp.

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio

9.10.Welltok Inc.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Key strategic moves and developments

LIST OF TABLE

STABLE 01.GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 02.HARDWARE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.SOFTWARE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, FOR SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 06.DEEP LEARNING ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.QUERYING METHOD ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 08.NATURAL LANGUAGE PROCESSING ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.CONTEXT AWARE PROCESSING ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 11.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR ROBOT-ASSISTED SURGERY, BY REGION, 2019–2027 ($MILLION)
TABLE 12.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR VIRTUAL NURSING ASSISTANT, BY REGION, 2019–2027 ($MILLION)
TABLE 13.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR ADMINISTRATIVE WORKFLOW ASSISTANCE, BY REGION, 2019–2027 ($MILLION)
TABLE 14.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR FRAUD DETECTION, BY REGION, 2019–2027 ($MILLION)
TABLE 15.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR DOSAGE ERROR REDUCTION, BY REGION, 2019–2027 ($MILLION)
TABLE 16.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR CLINICAL TRIAL PARTICIPANT IDENTIFIER, BY REGION, 2019–2027 ($MILLION)
TABLE 17.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR PRELIMINARY DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.GLOBAL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 20.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2019–2027 ($MILLION)
TABLE 21.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2027 ($MILLION)
TABLE 22.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 23.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR PAYER, BY REGION, 2019–2027 ($MILLION)
TABLE 24.ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 30.U.S. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 31.U.S. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 32.U.S. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 33.U.S. ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 34.CANADA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 35.CANADA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 36.CANADA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.CANADA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 38.MEXICO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 39.MEXICO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 40.MEXICO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.MEXICO ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 42.EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 43.EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 44.EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 45.EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 46.EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 47.GERMANY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 48.GERMANY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 49.GERMANY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 50.GERMANY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 51.FRANCE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 52.FRANCE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 53.FRANCE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.FRANCE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 55.UK ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 56.UK ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 57.UK ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 58.UK ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 59.ITALY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 60.ITALY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 61.ITALY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 62.ITALY ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 63.SPAIN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 64.SPAIN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 65.SPAIN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 66.SPAIN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 67.REST OF EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 68.REST OF EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 69.REST OF EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 70.REST OF EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 71.ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 72.ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 73.ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 74.ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 75.ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 76.JAPAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 77.JAPAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 78.JAPAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 79.JAPAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 80.CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 81.CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 82.CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 83.CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 84.AUSTRALIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 85.AUSTRALIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 86.AUSTRALIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 87.AUSTRALIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 88.INDIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 89.INDIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 90.INDIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 91.INDIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 92.SOUTH KOREA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 93.SOUTH KOREA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 94.SOUTH KOREA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 95.SOUTH KOREA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 96.TAIWAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 97.TAIWAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 98.TAIWAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 99.TAIWAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 100.REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 101.REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 102.REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 103.REST OF ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 104.LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 105.LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 106.LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 107.LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 108.LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 109.BRAZIL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 110.BRAZIL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 111.BRAZIL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 112.BRAZIL ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 113.SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 114.SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 115.SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 116.SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 117.SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 118.SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 119.SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 120.SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 121.REST OF LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERING, 2019–2027 ($MILLION)
TABLE 122.REST OF LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ALGORITHMS, 2019–2027 ($MILLION)
TABLE 123.REST OF LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 124.REST OF LAMEA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 125.ALPHABET INC.: COMPANY SNAPSHOT
TABLE 126.ALPHABET INC.: OPERATING SEGMENTS
TABLE 127.ALPHABET INC.: PRODUCT PORTFOLIO
TABLE 128.ENLITIC: COMPANY SNAPSHOT
TABLE 129.ENLITIC: PRODUCT PORTFOLIO
TABLE 130.GENERAL VISION: COMPANY SNAPSHOT
TABLE 131.GENERAL VISION: THREE TECHNOLOGIES
TABLE 132.GENERAL VISION: PRODUCT PORTFOLIO
TABLE 133.ICARBONX: COMPANY SNAPSHOT
TABLE 134.ICARBONX: PRODUCT PORTFOLIO
TABLE 135.INTEL CORPORATION: COMPANY SNAPSHOT
TABLE 136.INTEL CORPORATION: OPERATING SEGMENTS
TABLE 137.INTEL CORPORATION: PRODUCT PORTFOLIO
TABLE 138.IBM CORPORATION: COMPANY SNAPSHOT
TABLE 139.IBM: OPERATING SEGMENTS
TABLE 140.IBM: PRODUCT PORTFOLIO
TABLE 141.MICROSOFT CORPORATION: COMPANY SNAPSHOT
TABLE 142.MICROSOFT CORPORATION: OPERATING SEGMENTS
TABLE 143.MICROSOFT: PRODUCT PORTFOLIO
TABLE 144.NVIDIA: COMPANY SNAPSHOT
TABLE 145.NVIDIA: OPERATING SEGMENTS
TABLE 146.NVIDIA: PRODUCT PORTFOLIO
TABLE 147.NEXT IT: COMPANY SNAPSHOT
TABLE 148.NEXT IT: PRODUCT CATEGORIES
TABLE 149.NEXT IT: PRODUCT PORTFOLIO
TABLE 150.WELLTOK: COMPANY SNAPSHOT
TABLE 151.WELLTOK: PRODUCT CATEGORIES
TABLE 152.WELLTOK: PRODUCT PORTFOLIO
※본 조사보고서 [세계의 의료용 AI 시장 2019-2027 : 제공방식별 (하드웨어, 소프트웨어, 서비스), 알고리즘별, 용도별, 최종 사용자별] (코드 : AMR20PL047) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 의료용 AI 시장 2019-2027 : 제공방식별 (하드웨어, 소프트웨어, 서비스), 알고리즘별, 용도별, 최종 사용자별] 에 대해서 E메일 문의는 여기를 클릭하세요.